chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Back pain, Breast enlargement, Breast pain, Neck pain
Clinical narrative: Left breast twice the size of right breast; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GW0169) via an unspecified route of administration in the left arm on 27Apr2021 at 21:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included possible early COPD, asthma, penicillin allergy, allergy to sulfa (sulfonamide allergy) and allergy to drinking alcohol (alcohol allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ketorolac (MANUFACTURER UNKNOWN), fluticasone furoate (ARNUITY ELLIPTA), progesterone (MANUFACTURER UNKNOWN) and estradiol (ESTROGEN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received ocrilate (DERMABOND) for unknown indication on an unknown date and experienced drug allergy.  On 28Apr2021 at 12:00, the patient's left breast increased twice the size of right breast with pain that runs from left side of neck down through breast / armpit area and left back area. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left breast twice the size of right breast with pain that runs from left side of neck down through breast / armpit area and left back area were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Body temperature increased, Fatigue, Headache
Clinical narrative: Severe headache; Severe muscle aches; Joint pain more than normal; Joint pain more than normal; Severe nausea; Vomiting; Fatigue; Weakness; Vertigo; Temperature between 99-100F; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 28Apr2021 at 11:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, osteoarthritis, fibromyalgia, Sjogren's and allergy to cephalosporins (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications included pregabalin (LYRICA), duloxetine hydrochloride (CYMBALTA), lansoprazole (PREVACID), tramadol (MANUFACTURER UNKNOWN), sulindac (MANUFACTURER UNKNOWN) and we (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), furosemide (LASIX), adalimumab (HUMIRA), etanercept (ENBREL) and sulfamethoxazole; trimethoprim (BACTRIM) and experienced drug allergy with all these medications. On 28Apr2021 at 13:00, the patient experienced severe headache, severe muscle aches, more joint pain than normal, severe nausea and vomiting, severe fatigue and weakness, vertigo and body temperature between 99 to 100 Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, severe muscle aches, more joint pain than normal, severe nausea and vomiting, severe fatigue and weakness, vertigo and body temperature of 99 to 100 Fahrenheit was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Vomiting
Clinical narrative: Severe headache; Severe muscle aches; Joint pain more than normal; Joint pain more than normal; Severe nausea; Vomiting; Fatigue; Weakness; Vertigo; Temperature between 99-100F; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 28Apr2021 at 11:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, osteoarthritis, fibromyalgia, Sjogren's and allergy to cephalosporins (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications included pregabalin (LYRICA), duloxetine hydrochloride (CYMBALTA), lansoprazole (PREVACID), tramadol (MANUFACTURER UNKNOWN), sulindac (MANUFACTURER UNKNOWN) and we (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), furosemide (LASIX), adalimumab (HUMIRA), etanercept (ENBREL) and sulfamethoxazole; trimethoprim (BACTRIM) and experienced drug allergy with all these medications. On 28Apr2021 at 13:00, the patient experienced severe headache, severe muscle aches, more joint pain than normal, severe nausea and vomiting, severe fatigue and weakness, vertigo and body temperature between 99 to 100 Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, severe muscle aches, more joint pain than normal, severe nausea and vomiting, severe fatigue and weakness, vertigo and body temperature of 99 to 100 Fahrenheit was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Condition aggravated, Fatigue
Clinical narrative: Severe headache; Severe muscle aches; Joint pain more than normal; Joint pain more than normal; Severe nausea; Vomiting; Fatigue; Weakness; Vertigo; Temperature between 99-100F; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 28Apr2021 at 11:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, osteoarthritis, fibromyalgia, Sjogren's and allergy to cephalosporins (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications included pregabalin (LYRICA), duloxetine hydrochloride (CYMBALTA), lansoprazole (PREVACID), tramadol (MANUFACTURER UNKNOWN), sulindac (MANUFACTURER UNKNOWN) and we (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), furosemide (LASIX), adalimumab (HUMIRA), etanercept (ENBREL) and sulfamethoxazole; trimethoprim (BACTRIM) and experienced drug allergy with all these medications. On 28Apr2021 at 13:00, the patient experienced severe headache, severe muscle aches, more joint pain than normal, severe nausea and vomiting, severe fatigue and weakness, vertigo and body temperature between 99 to 100 Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, severe muscle aches, more joint pain than normal, severe nausea and vomiting, severe fatigue and weakness, vertigo and body temperature of 99 to 100 Fahrenheit was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Myalgia, Nausea, Pyrexia, Vertigo
Clinical narrative: Severe headache; Severe muscle aches; Joint pain more than normal; Joint pain more than normal; Severe nausea; Vomiting; Fatigue; Weakness; Vertigo; Temperature between 99-100F; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 28Apr2021 at 11:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, osteoarthritis, fibromyalgia, Sjogren's and allergy to cephalosporins (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications included pregabalin (LYRICA), duloxetine hydrochloride (CYMBALTA), lansoprazole (PREVACID), tramadol (MANUFACTURER UNKNOWN), sulindac (MANUFACTURER UNKNOWN) and we (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), furosemide (LASIX), adalimumab (HUMIRA), etanercept (ENBREL) and sulfamethoxazole; trimethoprim (BACTRIM) and experienced drug allergy with all these medications. On 28Apr2021 at 13:00, the patient experienced severe headache, severe muscle aches, more joint pain than normal, severe nausea and vomiting, severe fatigue and weakness, vertigo and body temperature between 99 to 100 Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, severe muscle aches, more joint pain than normal, severe nausea and vomiting, severe fatigue and weakness, vertigo and body temperature of 99 to 100 Fahrenheit was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Severe headache; Severe muscle aches; Joint pain more than normal; Joint pain more than normal; Severe nausea; Vomiting; Fatigue; Weakness; Vertigo; Temperature between 99-100F; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 28Apr2021 at 11:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, osteoarthritis, fibromyalgia, Sjogren's and allergy to cephalosporins (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications included pregabalin (LYRICA), duloxetine hydrochloride (CYMBALTA), lansoprazole (PREVACID), tramadol (MANUFACTURER UNKNOWN), sulindac (MANUFACTURER UNKNOWN) and we (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), furosemide (LASIX), adalimumab (HUMIRA), etanercept (ENBREL) and sulfamethoxazole; trimethoprim (BACTRIM) and experienced drug allergy with all these medications. On 28Apr2021 at 13:00, the patient experienced severe headache, severe muscle aches, more joint pain than normal, severe nausea and vomiting, severe fatigue and weakness, vertigo and body temperature between 99 to 100 Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, severe muscle aches, more joint pain than normal, severe nausea and vomiting, severe fatigue and weakness, vertigo and body temperature of 99 to 100 Fahrenheit was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Oral discomfort, Pharyngeal swelling
Clinical narrative: Mouth sores corner of lip to inside cheek area; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 10Apr2021 at 13:30 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, eczema, allergy to multiple antibiotic, allergy to nuts, latex immediate and delayed IgE 86 and Cyanoacrylate(Mecrylate)Epoxy allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included multivitamin, levothyroxine sodium (SYNTHYROID) (reported as Synthyroid.75) and hydroxyzine hydrochloride (HYDROXIZINE); all from unknown date for unknown indication and unknown if ongoing. The patient previously took cyclobenzaprine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 20Mar2021 at 14:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 18:00, the patient experienced mouth sores at the corner of lip to inside cheek area. It was unknown whether therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mouth sores at the corner of lip to inside cheek area was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blister, Cheilitis, Rash, Rash pruritic, Skin burning sensation
Clinical narrative: Mouth sores corner of lip to inside cheek area; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 10Apr2021 at 13:30 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, eczema, allergy to multiple antibiotic, allergy to nuts, latex immediate and delayed IgE 86 and Cyanoacrylate(Mecrylate)Epoxy allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included multivitamin, levothyroxine sodium (SYNTHYROID) (reported as Synthyroid.75) and hydroxyzine hydrochloride (HYDROXIZINE); all from unknown date for unknown indication and unknown if ongoing. The patient previously took cyclobenzaprine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 20Mar2021 at 14:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 18:00, the patient experienced mouth sores at the corner of lip to inside cheek area. It was unknown whether therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mouth sores at the corner of lip to inside cheek area was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Skin exfoliation, Stomatitis, Swelling face
Clinical narrative: Mouth sores corner of lip to inside cheek area; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 10Apr2021 at 13:30 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, eczema, allergy to multiple antibiotic, allergy to nuts, latex immediate and delayed IgE 86 and Cyanoacrylate(Mecrylate)Epoxy allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included multivitamin, levothyroxine sodium (SYNTHYROID) (reported as Synthyroid.75) and hydroxyzine hydrochloride (HYDROXIZINE); all from unknown date for unknown indication and unknown if ongoing. The patient previously took cyclobenzaprine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 20Mar2021 at 14:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 18:00, the patient experienced mouth sores at the corner of lip to inside cheek area. It was unknown whether therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mouth sores at the corner of lip to inside cheek area was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Stomatitis
Clinical narrative: Mouth sores corner of lip to inside cheek area; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 10Apr2021 at 13:30 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, eczema, allergy to multiple antibiotic, allergy to nuts, latex immediate and delayed IgE 86 and Cyanoacrylate(Mecrylate)Epoxy allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included multivitamin, levothyroxine sodium (SYNTHYROID) (reported as Synthyroid.75) and hydroxyzine hydrochloride (HYDROXIZINE); all from unknown date for unknown indication and unknown if ongoing. The patient previously took cyclobenzaprine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 20Mar2021 at 14:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 18:00, the patient experienced mouth sores at the corner of lip to inside cheek area. It was unknown whether therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mouth sores at the corner of lip to inside cheek area was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Hyperhidrosis
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-HCP (patient). A 27-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine,  solution for injection, batch/lot# not reported), via an unspecified route of administration, on May 1, 2021, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. On unspecified date, patient experienced 20 to 30 seconds of dizziness. It went away. He also felt lightheaded for 20 to 30 seconds; began having chest heaviness and became sweaty almost immediately after the dizziness, while walking to the observation room. On unspecified date in May 2021, patient experienced high heart rate. Patient inquired if any people reported this issue and how often. He wanted to know if he can take the second dose or not because he experienced increased heart rate after first dose of Pfizer COVID-19 vaccine this weekend on May 1, 2021. Referred to HCP or vaccination provider to determine if he had a severe allergic reaction and if he should receive a second dose of the vaccine. Inquired if there are any  general blood tests to check for allergies to the vaccine. The patient underwent lab tests and procedures, which included heart rate results high on unspecified date in May 2021. The outcome of 20-30 seconds dizziness; went away or felt lightheaded as well for 20-30 seconds recovered on unspecified date; and for remaining events unknown. No follow-up attempts needed. Information about batch/lot number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Heart rate, Heart rate increased, Hyperhidrosis
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-HCP (patient). A 27-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine,  solution for injection, batch/lot# not reported), via an unspecified route of administration, on May 1, 2021, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. On unspecified date, patient experienced 20 to 30 seconds of dizziness. It went away. He also felt lightheaded for 20 to 30 seconds; began having chest heaviness and became sweaty almost immediately after the dizziness, while walking to the observation room. On unspecified date in May 2021, patient experienced high heart rate. Patient inquired if any people reported this issue and how often. He wanted to know if he can take the second dose or not because he experienced increased heart rate after first dose of Pfizer COVID-19 vaccine this weekend on May 1, 2021. Referred to HCP or vaccination provider to determine if he had a severe allergic reaction and if he should receive a second dose of the vaccine. Inquired if there are any  general blood tests to check for allergies to the vaccine. The patient underwent lab tests and procedures, which included heart rate results high on unspecified date in May 2021. The outcome of 20-30 seconds dizziness; went away or felt lightheaded as well for 20-30 seconds recovered on unspecified date; and for remaining events unknown. No follow-up attempts needed. Information about batch/lot number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Hypersensitivity, Hypoaesthesia oral, Lip swelling, Pyrexia
Clinical narrative: fever; vertigo; my tongue swelled up a bit and went numb; my tongue swelled up a bit and went numb/ my upper lip also swelled up and went numb as did the gums around my teeth// my upper lip also swelled up and went numb as did the gums around my teeth; my upper lip also swelled up and went numb as did the gums around my teeth; my upper lip also swelled up and went numb as did the gums around my teeth; This is a spontaneous report from a contactable consumer.  A 55-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, formulation: solution for injection, lot number: EW0161), via an unspecified route of administration, in arm left on 15Apr2021 at 08:45 as dose 2, single (age at vaccination 55 years) for covid-19 immunisation. Medical history included high cholesterol. Concomitant medication(s) included atorvastatin calcium (LIPITOR); cetirizine hydrochloride, pseudoephedrine hydrochloride (ZYRTEC-D); vitamin d nos; probiotics; vitamin b nos, all since an unknown date. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, formulation: solution for injection, lot number: ER8732), via an unspecified route of administration, in arm left on 24Mar2021 at 09:00 as dose 1, single (age at vaccination 55 years) for covid-19 immunisation and her tongue swelled up a bit and went numb. The patient took dose 2 and on 15Apr2021 at 08:45 events [similar to dose 1] like her tongue swelled up a bit and went numb occurred. Different from dose 1, her upper lip also swelled up and went numb as did the gums around her teeth on 15Apr2021 at 08:45. This continued off and on for 10 days. Some days no numbness. Other days a little numbness that would go away in an hour or so. Also on the 2nd day on 16Apr2021, she ran a fever and had a little vertigo. That went away overnight. None of the swelling or numbness required the use of an Epi Pen. She had never had an allergic reaction to a vaccine in my life prior to the Covid vaccine. The outcome of all the events was recovered on an unknown date in Apr2021.  Follow-up attempts are completed. No further information is expected
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue, Vertigo
Clinical narrative: fever; vertigo; my tongue swelled up a bit and went numb; my tongue swelled up a bit and went numb/ my upper lip also swelled up and went numb as did the gums around my teeth// my upper lip also swelled up and went numb as did the gums around my teeth; my upper lip also swelled up and went numb as did the gums around my teeth; my upper lip also swelled up and went numb as did the gums around my teeth; This is a spontaneous report from a contactable consumer.  A 55-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, formulation: solution for injection, lot number: EW0161), via an unspecified route of administration, in arm left on 15Apr2021 at 08:45 as dose 2, single (age at vaccination 55 years) for covid-19 immunisation. Medical history included high cholesterol. Concomitant medication(s) included atorvastatin calcium (LIPITOR); cetirizine hydrochloride, pseudoephedrine hydrochloride (ZYRTEC-D); vitamin d nos; probiotics; vitamin b nos, all since an unknown date. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, formulation: solution for injection, lot number: ER8732), via an unspecified route of administration, in arm left on 24Mar2021 at 09:00 as dose 1, single (age at vaccination 55 years) for covid-19 immunisation and her tongue swelled up a bit and went numb. The patient took dose 2 and on 15Apr2021 at 08:45 events [similar to dose 1] like her tongue swelled up a bit and went numb occurred. Different from dose 1, her upper lip also swelled up and went numb as did the gums around her teeth on 15Apr2021 at 08:45. This continued off and on for 10 days. Some days no numbness. Other days a little numbness that would go away in an hour or so. Also on the 2nd day on 16Apr2021, she ran a fever and had a little vertigo. That went away overnight. None of the swelling or numbness required the use of an Epi Pen. She had never had an allergic reaction to a vaccine in my life prior to the Covid vaccine. The outcome of all the events was recovered on an unknown date in Apr2021.  Follow-up attempts are completed. No further information is expected
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gingival swelling, Hypoaesthesia oral, Lip swelling, Pyrexia, Swollen tongue
Clinical narrative: fever; vertigo; my tongue swelled up a bit and went numb; my tongue swelled up a bit and went numb/ my upper lip also swelled up and went numb as did the gums around my teeth// my upper lip also swelled up and went numb as did the gums around my teeth; my upper lip also swelled up and went numb as did the gums around my teeth; my upper lip also swelled up and went numb as did the gums around my teeth; This is a spontaneous report from a contactable consumer.  A 55-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, formulation: solution for injection, lot number: EW0161), via an unspecified route of administration, in arm left on 15Apr2021 at 08:45 as dose 2, single (age at vaccination 55 years) for covid-19 immunisation. Medical history included high cholesterol. Concomitant medication(s) included atorvastatin calcium (LIPITOR); cetirizine hydrochloride, pseudoephedrine hydrochloride (ZYRTEC-D); vitamin d nos; probiotics; vitamin b nos, all since an unknown date. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, formulation: solution for injection, lot number: ER8732), via an unspecified route of administration, in arm left on 24Mar2021 at 09:00 as dose 1, single (age at vaccination 55 years) for covid-19 immunisation and her tongue swelled up a bit and went numb. The patient took dose 2 and on 15Apr2021 at 08:45 events [similar to dose 1] like her tongue swelled up a bit and went numb occurred. Different from dose 1, her upper lip also swelled up and went numb as did the gums around her teeth on 15Apr2021 at 08:45. This continued off and on for 10 days. Some days no numbness. Other days a little numbness that would go away in an hour or so. Also on the 2nd day on 16Apr2021, she ran a fever and had a little vertigo. That went away overnight. None of the swelling or numbness required the use of an Epi Pen. She had never had an allergic reaction to a vaccine in my life prior to the Covid vaccine. The outcome of all the events was recovered on an unknown date in Apr2021.  Follow-up attempts are completed. No further information is expected
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: fever; vertigo; my tongue swelled up a bit and went numb; my tongue swelled up a bit and went numb/ my upper lip also swelled up and went numb as did the gums around my teeth// my upper lip also swelled up and went numb as did the gums around my teeth; my upper lip also swelled up and went numb as did the gums around my teeth; my upper lip also swelled up and went numb as did the gums around my teeth; This is a spontaneous report from a contactable consumer.  A 55-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, formulation: solution for injection, lot number: EW0161), via an unspecified route of administration, in arm left on 15Apr2021 at 08:45 as dose 2, single (age at vaccination 55 years) for covid-19 immunisation. Medical history included high cholesterol. Concomitant medication(s) included atorvastatin calcium (LIPITOR); cetirizine hydrochloride, pseudoephedrine hydrochloride (ZYRTEC-D); vitamin d nos; probiotics; vitamin b nos, all since an unknown date. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, formulation: solution for injection, lot number: ER8732), via an unspecified route of administration, in arm left on 24Mar2021 at 09:00 as dose 1, single (age at vaccination 55 years) for covid-19 immunisation and her tongue swelled up a bit and went numb. The patient took dose 2 and on 15Apr2021 at 08:45 events [similar to dose 1] like her tongue swelled up a bit and went numb occurred. Different from dose 1, her upper lip also swelled up and went numb as did the gums around her teeth on 15Apr2021 at 08:45. This continued off and on for 10 days. Some days no numbness. Other days a little numbness that would go away in an hour or so. Also on the 2nd day on 16Apr2021, she ran a fever and had a little vertigo. That went away overnight. None of the swelling or numbness required the use of an Epi Pen. She had never had an allergic reaction to a vaccine in my life prior to the Covid vaccine. The outcome of all the events was recovered on an unknown date in Apr2021.  Follow-up attempts are completed. No further information is expected
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray, Chest pain, Chills, Ear pain, Electrocardiogram
Clinical narrative: Headache; Teeth-chattering chills; Achy muscles; Vertigo; Lethargy; Fever; Soreness in arm; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 22Apr2021 at 16:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 01Apr2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 16:30, the patient experienced soreness in arm. On 22Apr2021 at 22:00, the patient experienced fever, teeth-chattering chills, achy muscles everywhere, vertigo and headache. Symptoms continued to increase in valence through next day and remained steady through following night and third day. Third day had slightly improved symptoms. 4th day fever broke, achy muscles and lethargy decreased. On day 5, slight headache, arm still sore otherwise on the mend. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, achy muscles and lethargy was resolved on 26Apr2021 and teeth-chattering chills and vertigo was resolved on an unknown date in Apr2021. The clinical outcome of event soreness in arm and headache was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count, Headache, Lethargy, Metabolic function test, Myalgia
Clinical narrative: Headache; Teeth-chattering chills; Achy muscles; Vertigo; Lethargy; Fever; Soreness in arm; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 22Apr2021 at 16:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 01Apr2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 16:30, the patient experienced soreness in arm. On 22Apr2021 at 22:00, the patient experienced fever, teeth-chattering chills, achy muscles everywhere, vertigo and headache. Symptoms continued to increase in valence through next day and remained steady through following night and third day. Third day had slightly improved symptoms. 4th day fever broke, achy muscles and lethargy decreased. On day 5, slight headache, arm still sore otherwise on the mend. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, achy muscles and lethargy was resolved on 26Apr2021 and teeth-chattering chills and vertigo was resolved on an unknown date in Apr2021. The clinical outcome of event soreness in arm and headache was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neck pain, Oropharyngeal pain, Pain, Pain in extremity, Pain of skin
Clinical narrative: Headache; Teeth-chattering chills; Achy muscles; Vertigo; Lethargy; Fever; Soreness in arm; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 22Apr2021 at 16:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 01Apr2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 16:30, the patient experienced soreness in arm. On 22Apr2021 at 22:00, the patient experienced fever, teeth-chattering chills, achy muscles everywhere, vertigo and headache. Symptoms continued to increase in valence through next day and remained steady through following night and third day. Third day had slightly improved symptoms. 4th day fever broke, achy muscles and lethargy decreased. On day 5, slight headache, arm still sore otherwise on the mend. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, achy muscles and lethargy was resolved on 26Apr2021 and teeth-chattering chills and vertigo was resolved on an unknown date in Apr2021. The clinical outcome of event soreness in arm and headache was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Peripheral swelling, Pyrexia, Sensitive skin, Viral pericarditis
Clinical narrative: Headache; Teeth-chattering chills; Achy muscles; Vertigo; Lethargy; Fever; Soreness in arm; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 22Apr2021 at 16:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 01Apr2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 16:30, the patient experienced soreness in arm. On 22Apr2021 at 22:00, the patient experienced fever, teeth-chattering chills, achy muscles everywhere, vertigo and headache. Symptoms continued to increase in valence through next day and remained steady through following night and third day. Third day had slightly improved symptoms. 4th day fever broke, achy muscles and lethargy decreased. On day 5, slight headache, arm still sore otherwise on the mend. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, achy muscles and lethargy was resolved on 26Apr2021 and teeth-chattering chills and vertigo was resolved on an unknown date in Apr2021. The clinical outcome of event soreness in arm and headache was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Headache, Lethargy, Myalgia, Pain in extremity
Clinical narrative: Headache; Teeth-chattering chills; Achy muscles; Vertigo; Lethargy; Fever; Soreness in arm; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 22Apr2021 at 16:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 01Apr2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 16:30, the patient experienced soreness in arm. On 22Apr2021 at 22:00, the patient experienced fever, teeth-chattering chills, achy muscles everywhere, vertigo and headache. Symptoms continued to increase in valence through next day and remained steady through following night and third day. Third day had slightly improved symptoms. 4th day fever broke, achy muscles and lethargy decreased. On day 5, slight headache, arm still sore otherwise on the mend. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, achy muscles and lethargy was resolved on 26Apr2021 and teeth-chattering chills and vertigo was resolved on an unknown date in Apr2021. The clinical outcome of event soreness in arm and headache was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Vertigo
Clinical narrative: Headache; Teeth-chattering chills; Achy muscles; Vertigo; Lethargy; Fever; Soreness in arm; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 22Apr2021 at 16:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 01Apr2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 16:30, the patient experienced soreness in arm. On 22Apr2021 at 22:00, the patient experienced fever, teeth-chattering chills, achy muscles everywhere, vertigo and headache. Symptoms continued to increase in valence through next day and remained steady through following night and third day. Third day had slightly improved symptoms. 4th day fever broke, achy muscles and lethargy decreased. On day 5, slight headache, arm still sore otherwise on the mend. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, achy muscles and lethargy was resolved on 26Apr2021 and teeth-chattering chills and vertigo was resolved on an unknown date in Apr2021. The clinical outcome of event soreness in arm and headache was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.